Adage Capital Partners
CPIX icon

Adage Capital Partners’s Cumberland Pharmaceuticals CPIX Stock Holding History

Adage Capital Partners’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-150,000
Closed -$635K – 865
2025
Q1 		$635K Buy
+150,000
New +$622K ﹤0.01% 806

Other funds holding CPIX

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Adage Capital Partners's CPIX Position: Q2 2025 in Review

Adage Capital Partners sold out of Cumberland Pharmaceuticals (CPIX) in Q2 2025, closing a stake of 150,000 shares — an estimated $635K sold.

Adage Capital Partners first reported a position in CPIX in Q1 2025 and held it in 1 quarter. The position peaked at $635K in Q1 2025. 31 funds tracked by Wall St. Rank hold CPIX as of Q2 2025.

  • Adage Capital Partners reported no remaining Cumberland Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Adage Capital Partners sold 150,000 Cumberland Pharmaceuticals shares in Q2 2025, an estimated $635K.
  • Adage Capital Partners first reported a position in Cumberland Pharmaceuticals in Q1 2025 and held it in 1 quarter.
  • Adage Capital Partners's Cumberland Pharmaceuticals position peaked at $635K in Q1 2025.
  • 31 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2025.

Based on Adage Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.